Journal article
Transrectal Prostate Biopsy-Associated Prophylaxis and Infectious Complications: Report of a Query to the Emerging Infections Network of the Infectious Diseases Society of America
Open forum infectious diseases, Vol.2(1), ofv002
12/01/2015
DOI: 10.1093/ofid/ofv002
PMCID: PMC4677157
PMID: 26677455
Abstract
Background. Fluoroquinolone-resistant infections after transrectal prostate biopsy (TRPB) are increasing.
Methods. Members of the Emerging Infections Network, a consortium of adult infectious diseases physicians sponsored by the Centers for Disease Control and Prevention and the Infectious Diseases Society of America, were administered an electronic 9-question survey regarding post-TRPB infections and associated prophylaxis.
Results were compared with respondent characteristics. Results. The overall response rate was 47% (552 of 1180). Of the 552 respondents, 234 (42%) reported that this problem was not applicable to their practice. The remaining 318 (58%) reported that, despite widespread recent changes in prophylactic regimens, fluoroquinolone monotherapy still was most common, but diverse alternate or supplemental oral and parenteral antibiotics (including imipenem) also were used. Reports of culture-guided prophylaxis were rare (9%). The most common duration of prophylaxis was a single prebiopsy antibiotic dose. However, 16%-23% of respondents reported prophylaxis continuing for >= 24 hours postbiopsy. Post-TRPB infections were reported as being more frequent now than 4 years ago, with sepsis and genitourinary presentations predominating, but with osteomyelitis, endocarditis, and epidural abscess also occurring. Infection isolates reportedly were usually resistant to the prophylactic regimen.
Conclusions. Emerging Infections Network members perceive post-TRPB infections as increasingly frequent, caused by resistant strains, and involving serious illness. Prophylactic approaches, although in flux, still usually entail ciprofloxacin monotherapy, which often is given for excessive durations. Multiple opportunities exist for infectious diseases specialists to partner with proceduralists in devising, studying, and implementing improved prophylaxis regimens for TRPB.
Details
- Title: Subtitle
- Transrectal Prostate Biopsy-Associated Prophylaxis and Infectious Complications: Report of a Query to the Emerging Infections Network of the Infectious Diseases Society of America
- Creators
- James R. Johnson - University of MinnesotaPhilip M. Polgreen - University of IowaSusan E. Beekmann - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Open forum infectious diseases, Vol.2(1), ofv002
- DOI
- 10.1093/ofid/ofv002
- PMID
- 26677455
- PMCID
- PMC4677157
- NLM abbreviation
- Open Forum Infect Dis
- ISSN
- 2328-8957
- eISSN
- 2328-8957
- Publisher
- Oxford University Press
- Number of pages
- 7
- Grant note
- Office of Research and Development, Medical Research Service, Department of Veterans Affairs; US Department of Veterans Affairs CK11-1102 / Grant or Cooperative Agreement FOA I01CX000920 / Veterans Affairs; US Department of Veterans Affairs CDC; United States Department of Health & Human Services; Centers for Disease Control & Prevention - USA
- Language
- English
- Date published
- 12/01/2015
- Academic Unit
- Infectious Diseases; Epidemiology; Injury Prevention Research Center; Internal Medicine
- Record Identifier
- 9984359770802771
Metrics
13 Record Views